A 15-day course of donepezil modulates spectral EEG dynamics related to target auditory stimuli in young, healthy adult volunteers.


Journal

Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology
ISSN: 1872-8952
Titre abrégé: Clin Neurophysiol
Pays: Netherlands
ID NLM: 100883319

Informations de publication

Date de publication:
05 2019
Historique:
received: 22 05 2015
revised: 17 11 2015
accepted: 20 11 2015
pubmed: 25 12 2015
medline: 18 2 2020
entrez: 25 12 2015
Statut: ppublish

Résumé

To identify possible electroencephalographic (EEG) markers of donepezil's effect on cortical activity in young, healthy adult volunteers at the group level. Thirty subjects were administered a daily dose of either 5mg donepezil or placebo for 15days in a double-blind, randomized, cross-over trial. The electroencephalogram during an auditory oddball paradigm was recorded from 58 scalp electrodes. Current source density (CSD) transformations were applied to EEG epochs. The event-related potential (ERP), inter-trial coherence (ITC: the phase consistency of the EEG spectrum) and event-related spectral perturbation (ERSP: the EEG power spectrum relative to the baseline) were calculated for the target (oddball) stimuli. The donepezil and placebo conditions differed in terms of the changes in delta/theta/alpha/beta ITC and ERSP in various regions of the scalp (especially the frontal electrodes) but not in terms of latency and amplitude of the P300-ERP component. Our results suggest that ITC and ERSP analyses can provide EEG markers of donepezil's effects in young, healthy, adult volunteers at a group level. Novel EEG markers could be useful to assess the therapeutic potential of drug candidates in Alzheimer's disease in healthy volunteers prior to the initiation of Phase II/III clinical studies in patients.

Identifiants

pubmed: 26699666
pii: S1388-2457(15)01119-0
doi: 10.1016/j.clinph.2015.11.018
pii:
doi:

Substances chimiques

Nootropic Agents 0
Donepezil 8SSC91326P

Types de publication

Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

863-875

Informations de copyright

Copyright © 2015 International Federation of Clinical Neurophysiology. Published by Elsevier B.V. All rights reserved.

Auteurs

Christopher Leroy (C)

INSERM U1171, Lille University Medical Center, Lille, France; Department of Clinical Neurophysiology, Lille University Medical Center, Lille, France. Electronic address: christopher.leroy87@gmail.com.

Jean-Louis Bourriez (JL)

INSERM U1171, Lille University Medical Center, Lille, France; Department of Clinical Neurophysiology, Lille University Medical Center, Lille, France.

Kathy Dujardin (K)

INSERM U1171, Lille University Medical Center, Lille, France; Department of Neurology and Movement Disorders, Lille University Medical Center, Lille, France.

Behnam Molaee-Ardekani (B)

INSERM U1171, Lille University Medical Center, Lille, France; Department of Clinical Neurophysiology, Lille University Medical Center, Lille, France.

Claudio Babiloni (C)

Department of Physiology and Pharmacology, University of Rome "La Sapienza", Rome, Italy; Department of Neuroscience, IRCCS San Raffaele Pisana, Rome, Italy.

Dominique Deplanque (D)

INSERM U1171, Lille University Medical Center, Lille, France; Department of Medical Pharmacology, Lille University Medical Center, Lille, France; CIC 1403 INSERM-CHU, Lille University Medical Center, Lille, France.

Amélie Ponchel (A)

INSERM U1171, Lille University Medical Center, Lille, France; Department of Medical Pharmacology, Lille University Medical Center, Lille, France.

Sophie Hennion (S)

INSERM U1171, Lille University Medical Center, Lille, France; Department of Clinical Neurophysiology, Lille University Medical Center, Lille, France.

Lucie Plomhause (L)

INSERM U1171, Lille University Medical Center, Lille, France; Department of Clinical Neurophysiology, Lille University Medical Center, Lille, France.

Hervé Devanne (H)

Department of Clinical Neurophysiology, Lille University Medical Center, Lille, France; ULCO, Calais, France.

Julie Deguil (J)

INSERM U1171, Lille University Medical Center, Lille, France; Department of Medical Pharmacology, Lille University Medical Center, Lille, France.

Pierre Payoux (P)

INSERM UMR 825 Brain Imaging and Neurological Dysfunctions, Toulouse, France.

Olivier Blin (O)

Department of Clinical Pharmacology, and CNRS UMR 7289, CIC-CPCET, Aix-Marseille University, Marseille, France.

Déborah Méligne (D)

INSERM UMR 825 Brain Imaging and Neurological Dysfunctions, Toulouse, France.

Joëlle Micallef (J)

Department of Clinical Pharmacology, and CNRS UMR 7289, CIC-CPCET, Aix-Marseille University, Marseille, France.

Nicolas Chauveau (N)

INSERM UMR 825 Brain Imaging and Neurological Dysfunctions, Toulouse, France.

Laura Lanteaume (L)

Department of Clinical Pharmacology, and CNRS UMR 7289, CIC-CPCET, Aix-Marseille University, Marseille, France.

Céline Vervueren (C)

INSERM UMR 825 Brain Imaging and Neurological Dysfunctions, Toulouse, France.

François Guimont (F)

Department of Clinical Pharmacology, and CNRS UMR 7289, CIC-CPCET, Aix-Marseille University, Marseille, France.

Claire Thalamas (C)

Department of Medical Pharmacology, INSERM CIC 1436, Toulouse University Medical Center, Toulouse, France.

Catherine Cassé-Perrot (C)

Department of Clinical Pharmacology, and CNRS UMR 7289, CIC-CPCET, Aix-Marseille University, Marseille, France.

Franck Rouby (F)

Department of Clinical Pharmacology, and CNRS UMR 7289, CIC-CPCET, Aix-Marseille University, Marseille, France.

Régis Bordet (R)

INSERM U1171, Lille University Medical Center, Lille, France; Department of Medical Pharmacology, Lille University Medical Center, Lille, France.

Philippe Derambure (P)

INSERM U1171, Lille University Medical Center, Lille, France; Department of Clinical Neurophysiology, Lille University Medical Center, Lille, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH